Tissue transglutaminase regulates β-catenin signaling through a c-Src-dependent mechanism

FASEB Journal

Volumn 27, Issue 8, 2013, Pages 3100-3112

  Condello, Salvatore ^a,b   Cao, Liyun ^a   Matei, Daniela ^a,b,c  

^a Department of Medicine ^*  (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

EMT; Fibronectin; Integrin; Wnt signaling

Indexed keywords

BETA CATENIN; CYCLIN D1; MYC PROTEIN; PROTEIN; PROTEIN C SRC; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; TYROSINE; UNCLASSIFIED DRUG; UVOMORULIN; WNT PROTEIN; CSK TYROSINE-PROTEIN KINASE; INTEGRIN; PROTEIN BINDING; PROTEIN TYROSINE KINASE; TISSUE TRANSGLUTAMINASE 2, HUMAN;

ARTICLE; CANCER CELL CULTURE; CELL ADHESION; CELL PROLIFERATION; CONTROLLED STUDY; GENE TARGETING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; ONCOGENE SRC; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; CONFOCAL MICROSCOPY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; OVARY TUMOR; PATHOLOGY; PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TUMOR CELL LINE; WESTERN BLOTTING;

BETA CATENIN; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN D1; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTEGRINS; MICROSCOPY, CONFOCAL; OVARIAN NEOPLASMS; PHOSPHORYLATION; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-MYC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES; TRANSGLUTAMINASES;

EID: 84881173677     PISSN: None     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.12-222620     Document Type: Article

References (51)

1. Pincus, J. H., and Waelsch, H. (1968) The specificity of transglutaminase. II. Structural requirements of the amine substrate. Arch. Biochem. Biophys. 126, 44-52
2. Akimov, S. S., and Belkin, A. M. (2001) Cell surface tissue transglutaminase is involved in adhesion and migration of monocytic cells on fibronectin. Blood 98, 1567-1576
3. Chen, S., Lin, F., Iismaa, S., Lee, K. N., Birckbichler, P. J., and Graham, R. M. (1996) +1-Adrenergic receptor signaling via Gh is subtype specific and independent of its transglutaminase activity. J. Biol. Chem. 271, 32385-32391
4. Nanda, N., Iismaa, S. E., Owens, W. A., Husain, A., Mackay, F., and Graham, R. M. (2001) Targeted inactivation of Gh/tissue transglutaminase II. J. Biol. Chem. 276, 20673-20678
5. Fesus, L., and Piacentini, M. (2002) Transglutaminase 2: an enigmatic enzyme with diverse functions. Trends Biochem. Sci. 27, 534-539
6. Mann, A. P., Verma, A., Sethi, G., Manavathi, B., Wang, H., Fok, J. Y., Kunnumakkara, A. B., Kumar, R., Aggarwal, B. B., and Mehta, K. (2006) Overexpression of tissue transglutaminase leads to constitutive activation of nuclear factor-+B in cancer cells: delineation of a novel pathway. Cancer Res. 66, 8788-8795
7. Satpathy, M., Cao, L., Pincheira, R., Emerson, R., Bigsby, R., Nakshatri, H., and Matei, D. (2007) Enhanced peritoneal ovarian tumor dissemination by tissue transglutaminase. Cancer Res. 67, 7194-7202
8. Verma, A., Wang, H., Manavathi, B., Fok, J. Y., Mann, A. P., Kumar, R., and Mehta, K. (2006) Increased expression of tissue transglutaminase in pancreatic ductal adenocarcinoma and its implications in drug resistance and metastasis. Cancer Res. 66, 10525-10533
9. Antonyak, M. A., Miller, A. M., Jansen, J. M., Boehm, J. E., Balkman, C. E., Wakshlag, J. J., Page, R. L., and Cerione, R. A. (2004) Augmentation of tissue transglutaminase expression and activation by epidermal growth factor inhibit doxorubicin-induced apoptosis in human breast cancer cells. J. Biol. Chem. 279, 41461-41467
10. Cao, L., Petrusca, D. N., Satpathy, M., Nakshatri, H., Petrache, I., and Matei, D. (2008) Tissue transglutaminase protects epithelial ovarian cancer cells from cisplatin-induced apoptosis by promoting cell survival signaling. Carcinogenesis 29, 1893-1900
11. Cao, L., Shao, M., Schilder, J., Guise, T., Mohammad, K. S., and Matei, D. (2012) Tissue transglutaminase links TGF-+, epithelial to mesenchymal transition and a stem cell phenotype in ovarian cancer. Oncogene 31, 2521-2534
12. Verma, A., and Mehta, K. (2007) Transglutaminase-mediated activation of nuclear transcription factor-+B in cancer cells: a new therapeutic opportunity. Curr. Cancer Drug Targets 7, 559-565
13. Satpathy, M., Shao, M., Emerson, R., Donner, D. B., and Matei, D. (2009) Tissue transglutaminase regulates matrix metalloproteinase-2 in ovarian cancer by modulating cAMP-response element-binding protein activity. J. Biol. Chem. 284, 15390-15399
14. Verma, A., Guha, S., Wang, H., Fok, J. Y., Koul, D., Abbruzzese, J., and Mehta, K. (2008) Tissue transglutaminase regulates focal adhesion kinase/AKT activation by modulating PTEN expression in pancreatic cancer cells. Clin. Cancer Res. 14, 1997-2005
15. Cadigan, K. M., and Nusse, R. (1997) Wnt signaling: a common theme in animal development. Genes Dev. 11, 3286-3305
16. Novak, A., and Dedhar, S. (1999) Signaling through betacatenin and Lef/Tcf. Cell. Mol. Life Sci. 56, 523-537
17. Shao, M., Cao, L., Shen, C., Satpathy, M., Chelladurai, B., Bigsby, R. M., Nakshatri, H., and Matei, D. (2009) Epithelial-tomesenchymal transition and ovarian tumor progression induced by tissue transglutaminase. Cancer Res. 69, 9192-9201
18. Thiery, J. P. (2002) Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer 2, 442-454
19. Gottardi, C. J., Wong, E., and Gumbiner, B. M. (2001) Ecadherin suppresses cellular transformation by inhibiting +-catenin signaling in an adhesion-independent manner. J. Cell Biol. 153, 1049-1060
20. Nelson, W. J., and Nusse, R. (2004) Convergence of Wnt, +-catenin, and cadherin pathways. Science 303, 1483-1487
21. Wu, R., Hendrix-Lucas, N., Kuick, R., Zhai, Y., Schwartz, D. R., Akyol, A., Hanash, S., Misek, D. E., Katabuchi, H., Williams, B. O., Fearon, E. R., and Cho, K. R. (2007) Mouse model of human ovarian endometrioid adenocarcinoma based on somatic defects in the Wnt/+-catenin and PI3K/Pten signaling pathways. Cancer Cell 11, 321-333
22. Wu, R., Zhai, Y., Fearon, E. R., and Cho, K. R. (2001) Diverse mechanisms of +-catenin deregulation in ovarian endometrioid adenocarcinomas. Cancer Res. 61, 8247-8255
23. Chau, W. K., Ip, C. K., Mak, A. S., Lai, H. C., and Wong, A. S. (2012) c-Kit mediates chemoresistance and tumor-initiating capacity of ovarian cancer cells through activation of Wnt/+-catenin-ATP-binding cassette G2 signaling. [E-pub ahead of print] Oncogene doi: 10.1038/onc.2012.290
24. Steg, A. D., Bevis, K. S., Katre, A. A., Ziebarth, A., Dobbin, Z. C., Alvarez, R. D., Zhang, K., Conner, M., and Landen, C. N. (2012) Stem cell pathways contribute to clinical chemoresistance in ovarian cancer. Clin. Cancer Res. 18, 869-881
25. Zhang, X. L., Peng, C. J., Peng, J., Jiang, L. Y., Ning, X. M., and Zheng, J. H. (2010) Prognostic role of Wnt7a expression in ovarian carcinoma patients. Neoplasma 57, 545-551
26. Usongo, M., and Farookhi, R. (2012) +-Catenin/Tcf-signaling appears to establish the murine ovarian surface epithelium (OSE) and remains active in selected postnatal OSE cells. BMC Dev. Biol. 12, 17
27. Hang, J., Zemskov, E. A., Lorand, L., and Belkin, A. M. (2005) Identification of a novel recognition sequence for fibronectin within the NH2-terminal +-sandwich domain of tissue transglutaminase. J. Biol. Chem. 280, 23675-23683
28. Tucholski, J., Lesort, M., and Johnson, G. V. (2001) Tissue transglutaminase is essential for neurite outgrowth in human neuroblastoma SH-SY5Y cells. Neuroscience 102, 481-491
29. Kasugai, S., Hasegawa, N., and Ogura, H. (1990) A simple in vitro cytotoxicity test using the MTT (3-(4,5)-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) colorimetric assay: analysis of eugenol toxicity on dental pulp cells (RPC-C2A). Jpn. J. Pharmacol. 52, 95-100
30. Morin, P. J. (1999) +-Catenin signaling and cancer. Bioessays 21, 1021-1030
31. Roura, S., Miravet, S., Piedra, J., Garcia de Herreros, A., and Dunach, M. (1999) Regulation of E-cadherin/catenin association by tyrosine phosphorylation. J. Biol. Chem. 274, 36734-36740
32. Hwang, J. Y., Mangala, L. S., Fok, J. Y., Lin, Y. G., Merritt, W. M., Spannuth, W. A., Nick, A. M., Fiterman, D. J., Vivas-Mejia, P. E., Deavers, M. T., Coleman, R. L., Lopez-Berestein, G., Mehta, K., and Sood, A. K. (2008) Clinical and biological significance of tissue transglutaminase in ovarian carcinoma. Cancer Res. 68, 5849-5858
33. Mangala, L. S., Fok, J. Y., Zorrilla-Calancha, I. R., Verma, A., and Mehta, K. (2007) Tissue transglutaminase expression promotes cell attachment, invasion and survival in breast cancer cells. Oncogene 26, 2459-2470
34. Morin, P. J., Sparks, A. B., Korinek, V., Barker, N., Clevers, H., Vogelstein, B., and Kinzler, K. W. (1997) Activation of +-catenin-Tcf signaling in colon cancer by mutations in +-catenin or APC. Science 275, 1787-1790
35. Liu, W., Dong, X., Mai, M., Seelan, R. S., Taniguchi, K., Krishnadath, K. K., Halling, K. C., Cunningham, J. M., Boardman, L. A., Qian, C., Christensen, E., Schmidt, S. S., Roche, P. C., Smith, D. I., and Thibodeau, S. N. (2000) Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating +-catenin/TCF signalling. Nat. Genet. 26, 146-147
36. Bafico, A., Liu, G., Goldin, L., Harris, V., and Aaronson, S. A. (2004) An autocrine mechanism for constitutive Wnt pathway activation in human cancer cells. Cancer Cell 6, 497-506
37. Burkhalter, R. J., Symowicz, J., Hudson, L. G., Gottardi, C. J., and Stack, M. S. (2011) Integrin regulation of +-catenin signaling in ovarian carcinoma. J. Biol. Chem. 286, 23467-23475
38. Novak, A., Hsu, S. C., Leung-Hagesteijn, C., Radeva, G., Papkoff, J., Montesano, R., Roskelley, C., Grosschedl, R., and Dedhar, S. (1998) Cell adhesion and the integrin-linked kinase regulate the LEF-1 and β-catenin signaling pathways. Proc. Natl. Acad. Sci. U. S. A. 95, 4374-4379
39. Coluccia, A. M., Benati, D., Dekhil, H., De Filippo, A., Lan, C., and Gambacorti-Passerini, C. (2006) SKI-606 decreases growth and motility of colorectal cancer cells by preventing pp60(c-Src)-dependent tyrosine phosphorylation of +-catenin and its nuclear signaling. Cancer Res. 66, 2279-2286
40. Shedden, K. A., Kshirsagar, M. P., Schwartz, D. R., Wu, R., Yu, H., Misek, D. E., Hanash, S., Katabuchi, H., Ellenson, L. H., Fearon, E. R., and Cho, K. R. (2005) Histologic type, organ of origin, and Wnt pathway status: effect on gene expression in ovarian and uterine carcinomas. Clin. Cancer Res. 11, 2123-2131
41. Yoshioka, S., King, M. L., Ran, S., Okuda, H., MacLean, J. A., 2nd, McAsey, M. E., Sugino, N., Brard, L., Watabe, K., and Hayashi, K. (2012) WNT7A regulates tumor growth and progression in ovarian cancer through the WNT/β-catenin pathway. Mol. Cancer Res. 10, 469-482
42. Schmid, S., Bieber, M., Zhang, F., Zhang, M., He, B., Jablons, D., and Teng, N. N. (2011) Wnt and hedgehog gene pathway expression in serous ovarian cancer. Int. J. Gynecol. Cancer 21, 975-980
43. Chen, X., Stoeck, A., Lee, S. J., Shih I. M., Wang, M. M., and Wang, T. L. (2010) Jagged1 expression regulated by Notch3 and Wnt/β-catenin signaling pathways in ovarian cancer. Oncotarget 1, 210-218
44. Matei, D., Graeber, T. G., Baldwin, R. L., Karlan, B. Y., Rao, J., and Chang, D. D. (2002) Gene expression in epithelial ovarian carcinoma. Oncogene 21, 6289-6298
45. Faverman, L., Mikhaylova, L., Malmquist, J., and Nurminskaya, M. (2008) Extracellular transglutaminase 2 activates +-catenin signaling in calcifying vascular smooth muscle cells. FEBS Lett. 582, 1552-1557
46. Li, B., Antonyak, M. A., Druso, J. E., Cheng, L., Nikitin, A. Y., and Cerione, R. A. (2010) EGF potentiated oncogenesis requires a tissue transglutaminase-dependent signaling pathway leading to Src activation. Proc. Natl. Acad. Sci. U. S. A. 107, 1408-1413
47. Karni, R., Gus, Y., Dor, Y., Meyuhas, O., and Levitzki, A. (2005) Active Src elevates the expression of β-catenin by enhancement of cap-dependent translation. Mol. Cell. Biol. 25, 5031-5039
48. Kumar, A., Gao, H., Xu, J., Reuben, J., Yu, D., and Mehta, K. (2011) Evidence that aberrant expression of tissue transglutaminase promotes stem cell characteristics in mammary epithelial cells. PLoS One 6, e20701
49. Wang, Y., Krivtsov, A. V., Sinha, A. U., North, T. E., Goessling, W., Feng, Z., Zon, L. I., and Armstrong, S. A. (2010) The Wnt/β-catenin pathway is required for the development of leukemia stem cells in AML. Science 327, 1650-1653
50. Silva-Vargas, V., Lo Celso, C., Giangreco, A., Ofstad, T., Prowse, D. M., Braun, K. M., and Watt, F. M. (2005) +-Catenin and Hedgehog signal strength can specify number and location of hair follicles in adult epidermis without recruitment of bulge stem cells. Dev. Cell 9, 121-131
51. Hoffmeyer, K., Raggioli, A., Rudloff, S., Anton, R., Hierholzer, A., Del Valle, I., Hein, K., Vogt, R., and Kemler, R. (2012) Wnt/β-catenin signaling regulates telomerase in stem cells and cancer cells. Science 336, 1549-1554